ProPhase Labs Inc (PRPH)
Fair Value19.1% Upside
Undervalued
Market Cap201.857 K
P/E—
Yield0.0%
HealthWeak
OTC Markets
Astellas Pharma Inc (ALPMY)
Fair Value43.0% Upside
Undervalued
Analyst22.7% Upside
Market Cap25.427 B
P/E11.0x
Yield0.0%
HealthGreat
OTC Markets
Bayer AG PK (BAYRY)
Fair Value11.6% Upside
Fair
Analyst27.0% Upside
Market Cap48.558 B
P/E—
Yield0.2%
HealthGood
OTC Markets
Biosyent Inc (BIOYF)
Fair Value2.8% Upside
Fair
Market Cap133.6 M
P/E18.9x
Yield1.4%
HealthGreat
OTC Markets
Daiichi Sankyo Co Ltd ADR (DSNKY)
Fair Value35.5% Upside
Undervalued
Analyst33.9% Upside
Market Cap31.667 B
P/E18.8x
Yield0.0%
HealthGood
OTC Markets
Elite Pharma Inc (ELTP)
Fair Value31.5% Upside
Undervalued
Market Cap241.3 M
P/E4.3x
Yield0.0%
HealthGreat
OTC Markets
Grown Rogue International Inc (GRUSF)
Fair Value-36.8% Downside
Overvalued
Market Cap99.799 M
P/E—
Yield0.0%
HealthGood
OTC Markets
GSK plc (GLAXF)
Fair Value26.9% Upside
Undervalued
Market Cap93.369 B
P/E14.8x
Yield3.9%
HealthGreat
OTC Markets
Hepion Pharmaceuticals Inc (HEPA)
Fair Value-11.4% Downside
Fair
Market Cap9.822 M
P/E—
Yield0.0%
HealthGood
OTC Markets
Kaya Holdings Inc (KAYS)
Fair Value84.6% Upside
Bargain
Market Cap892.363 K
P/E—
Yield0.0%
HealthFair
OTC Markets
Marimed Inc (MRMD)
Fair Value37.4% Upside
Undervalued
Analyst277.1% Upside
Market Cap26.601 M
P/E—
Yield0.0%
HealthFair
OTC Markets
Novartis AG (NVSEF)
Fair Value8.7% Upside
Fair
Market Cap266.3 B
P/E20.9x
Yield3.5%
HealthGreat
OTC Markets
Provectus Biopharmaceuticals Inc (PVCT)
Fair Value6.0% Upside
Fair
Market Cap22.338 M
P/E—
Yield0.0%
HealthWeak
OTC Markets